ALA Arovella Therapeutics Ltd

Watchlist

20min DelayNot Open Jan 14 16:00 AET

195.99MMarket Cap-20.56P/E (Static)

Arovella Therapeutics Ltd Key Stats

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2026/FY	-- / 0.000	--
--	2025/FY	-- / 0.000	--
--	2023/FY	405.900K / 379.590K	--
--	2022/FY	295.810K / 1.335M	--
--	2021/FY	257.350K / 485.000K	--

DatePeriodRevenue/EstimateEarnings Call

--2026/FY-- / 0.000--

--2025/FY-- / 0.000--

--2023/FY405.900K / 379.590K--

--2022/FY295.810K / 1.335M--

--2021/FY257.350K / 485.000K--

Unlock Free Earnings Estimates

Open Account

Arovella Therapeutics Ltd: Arovella receives R&D tax rebate of $3.0 million

Oct 25, 2024 07:55

Arovella Therapeutics Ltd: Appendix 4E and Annual Report

Aug 22, 2024 07:43

Arovella Therapeutics Ltd: Appendix 4D and Half Year Report

Feb 28, 2024 09:43

Arovella Therapeutics Ltd: Appendix 4E and Annual Report

Aug 31, 2023 08:16

Overall

No Data